Venofer and Infusion site extravasation - a phase IV clinical study of FDA data

Summary:

Infusion site extravasation is reported as a side effect among people who take Venofer (iron sucrose), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Anaemia.

The phase IV clinical study analyzes which people have Infusion site extravasation when taking Venofer. It is created by eHealthMe based on reports of 8,801 people who have side effects when taking Venofer from the FDA, and is updated regularly.

What is Venofer?

Venofer has active ingredients of iron sucrose. It is often used in anemia. eHealthMe is studying from 8,895 Venofer users. Check the latest studies of Venofer.

What is Infusion site extravasation?

Infusion site extravasation (flow of (blood or lymph) from infusion site) is found to be associated with 648 drugs and 590 conditions by eHealthMe. Check the latest studies of Infusion site extravasation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

8,801 people reported to have side effects when taking Venofer.
Among them, 56 people (0.64%) have Infusion site extravasation.

Could Venofer cause Infusion site extravasation?

Among these 56 people:

How long have people been on Venofer when they have Infusion site extravasation? *

What is the gender of people who have Infusion site extravasation when taking Venofer? *

female: 71.74 %
male: 28.26 %

What is the age of people who have Infusion site extravasation when taking Venofer? *

What are other drugs people take besides Venofer? *

What are other side effects people have besides Infusion site extravasation? *

Infusion Site Pain: 12 people, 21.43%
Infusion Site Discoloration: 10 people, 17.86%
Skin Discoloration: 9 people, 16.07%
Peripheral Swelling: 8 people, 14.29%
Dizziness: 7 people, 12.50%
Body Temperature Fluctuation: 6 people, 10.71%
Red Blood Cell Count Decreased: 6 people, 10.71%
Urinary Tract Infection: 6 people, 10.71%
Ulcer Haemorrhage (bleeding ulcer): 6 people, 10.71%
Drug Level Below Therapeutic: 6 people, 10.71%

What are the existing conditions these people have? *

Anaemia (lack of blood): 10 people, 17.86%
Iron Deficiency Anaemia: 9 people, 16.07%
Prostatic Disorder: 6 people, 10.71%
Ulcer Haemorrhage (bleeding ulcer): 6 people, 10.71%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 6 people, 10.71%
Joint Pain: 6 people, 10.71%
Chronic Renal Failure (kidney failure): 3 people, 5.36%
Postpartum Haemorrhage (bleeding in woman after she has given birth): 2 people, 3.57%
High Blood Pressure: 1 person, 1.79%
Anaemia Of Pregnancy: 1 person, 1.79%

* Approximation only. Some reports may have incomplete information.

Do you take Venofer and have Infusion site extravasation?

- Check whether Infusion site extravasation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Venofer:

Venofer (8,895 reports)

Browse all side effects of Venofer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion site extravasation:

Infusion site extravasation (648 drugs)

Browse all the conditions that are associated with Infusion site extravasation:

Infusion site extravasation (590 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on iron sucrose (the active ingredients of Venofer) and Venofer (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.